Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Midas Medici Group Holdings, Inc.Financial_Report.xls
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 10-Q/A
(Amendment No. 1)

  (Mark One)
  
x
QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the quarterly period ended June 30, 2011
 
 
o
TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT
 
For the transition period from ________________ to _______________
 
000-52621
(Commission file number)
 
 
Graphic
 
Midas Medici Group Holdings, Inc.
(Exact name of registrant as specified in its charter)
 
Delaware
 
37-1532843
(State or other jurisdiction of incorporation or organization)   
 
(IRS Employer Identification No.)
     
                                                                                                 
 
445 Park Avenue, 20th Floor
New York, New York 10022
(Address of principal executive offices)
 
(212) 792-0920
(Issuer's telephone number)

N/A
 (Former name, former address and former fiscal year, if changed since last report)
 
Indicate by check mark whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes x    No o
 
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or such shorter period that the registrant was required to submit and post such files.   Yes x     No o
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a small reporting company.  See definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
 
Large accelerated filer o
Accelerated filer  o
Non-accelerated filer   o  (Do not check if a smaller reporting company)  
Smaller reporting company  x
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes  o  No x
 
There were 9,840,091 shares of the issuer's common stock outstanding as of August 10, 2011.
 
 
 
1

 

Explanatory Note

The purpose of this Amendment No. 1 (the “Amendment”) to Midas Medici Group Holding, Inc.’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2011, filed with the Securities and Exchange Commission on August 16, 2011 (the “Form 10-Q”), is solely to furnish Exhibit 101 to the Form 10-Q in accordance with Rule 405 of Regulation S-T. Exhibit 101 to this report provides the condensed consolidated financial statements and related notes from the Form 10-Q formatted in XBRL (eXtensible Business Reporting Language).
 
No other changes have been made to the Form 10-Q. This Amendment speaks as of the original filing date of the Form 10-Q, does not reflect events that may have occurred subsequent to the original filing date, and does not modify or update in any way disclosures made in the original Form 10-Q.
 
Pursuant to Rule 406T of Regulation S-T, the interactive data files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.
 
 
 
2

 
 
 
Item 6.
Exhibits
                                                                                                                                                               
(a)  
Exhibits
 
Exhibit Number
Description of Exhibit
 
     
31.1
Certifications of Principal Executive Officer pursuant to Rule 13a-14 and Rule 15d-14(a), promulgated under the Securities Exchange Act of 1934, as amended*
 
     
31.2
Certifications of Principal Financial and Accounting Officer pursuant to Rule 13a-14 and Rule 15d-14(a), promulgated under the Securities Exchange Act of 1934, as amended*
 
     
32.1
Certifications of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*
 
     
32.2
Certifications of Principal and Accounting Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*
 
     
101.INS
Xbrl Instance Document**
   
101.SCH
Xbrl Taxonomy Extension Schema Document**
   
101.CAL
Xbrl Taxonomy Extension Calculation Linkbase Document**
   
101.DEF
Xbrl Taxonomy Extension Definition Linkbase Document**
   
101.LAB
Xbrl Taxonomy Extension Labels Linkbase Document**
   
101.PRE
Xbrl Taxonomy Extension Presentation Linkbase  Document**
                      
___________________
*           These exhibits were previously included or incorporated by reference in Midas Medici Group Holdings, Inc. Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2011, filed with the Securities and Exchange Commission on August 16, 2011.

 **        The XBRL related information in Exhibit 101 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability of that section and shall not be incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing or document.
 
 
 
3

 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
Midas Medici Group Holdings, Inc.
 
       
September 2, 2011
By:
/s/ Nana Baffour
 
   
Nana Baffour
 
   
Chief Executive Officer (Principal Executive Officer)
 
       
       
       
   
/s/ Johnson Kachidza
 
   
Johnson Kachidza
 
   
Chief Financial Officer (Principal Financial and Accounting Officer)
 
 
 
 
 
4